Orbs Expands to Fantom to Enhance L3 DeFi Capabilities
Orbs continues to push the boundaries of multi-chain interoperability as part of its Orbs 3.0…
Orbs continues to push the boundaries of multi-chain interoperability as part of its Orbs 3.0…
Beijing, China–(Newsfile Corp. – March 8, 2022) – Chinese interior designer Duan Yuan, who is…
Organization Requirements Include Secure, Reliable Colocation and Native Cloud Onramps in a State-of-the-Art Data Center…
Fourth Consecutive Year of Strong Sales Growth; Full Year Net Sales Increased 20% to $375.1…
Company’s enzymatic DNA printing on demand technology recognized among top-ranked in the biotech category. SOUTH…
Concentrated solar thermal energy company joins the ranks of past winners including Microsoft, SpaceX, Moderna,…
The solution will provide day-ahead and real-time energy price forecasting to maximize the value and…
CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable…
Step joins the ranks of legendary companies like SpaceX, Shopify, Snap and more. PALO ALTO,…
CHARLOTTE, N.C.–(BUSINESS WIRE)–#ABBYYOne–ABBYY launched its new global partner program, ABBYYOne, to enable partners to accelerate…
Acquisition to bring Google speed and scale to Mandiant’s unparalleled intelligence and expertise – at…
The largest distributor of beverage alcohol in North America turns to Ryder’s supply chain team…
DUBLIN–(BUSINESS WIRE)–The “United States DoD Artificial Intelligence Growth Opportunities” report has been added to ResearchAndMarkets.com’s…
The first comprehensive taxonomy of digital infrastructure job roles launches to help expand and diversify…
SAN DIEGO–(BUSINESS WIRE)–Go!Foton, a world leader in optical components and connectivity solutions for carriers and…
VAXIMM technology enables fast generation and delivery of personalized T-cell cancer vaccines and may overcome…
FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of…
Press Release Basel, Switzerland, March 08, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical…
Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…